ARS Wealth Advisors Group
PFE icon

ARS Wealth Advisors Group’s Pfizer PFE Stock Holding History

ARS Wealth Advisors Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.03M Buy
36,016
+72
+0.2% +$1.92K 0.07% 95
2026
Q2 		$866K Buy
35,944
+8,538
+31% +$223K 0.07% 102
2026
Q1 		$770K Sell
27,406
-1,351
-5% -$36K 0.07% 99
2025
Q4 		$716K Buy
28,757
+2,170
+8% +$54.7K 0.06% 95
2025
Q3 		$677K Buy
26,587
+510
+2% +$12.6K 0.07% 94
2025
Q2 		$632K Buy
26,077
+1,838
+8% +$42.9K 0.07% 94
2025
Q1 		$614K Sell
24,239
-728
-3% -$19K 0.09% 83
2024
Q4 		$662K Buy
24,967
+1,176
+5% +$31.9K 0.09% 81
2024
Q3 		$689K Buy
23,791
+794
+3% +$23.2K 0.08% 87
2024
Q2 		$643K Sell
22,997
-4,222
-16% -$116K 0.08% 85
2024
Q1 		$755K Sell
27,219
-4,962
-15% -$138K 0.1% 79
2023
Q4 		$926K Sell
32,181
-158,885
-83% -$4.8M 0.14% 67
2023
Q3 		$6.34M Sell
191,066
-8,693
-4% -$307K 1.04% 37
2023
Q2 		$7.33M Buy
199,759
+8,376
+4% +$326K 1.16% 34
2023
Q1 		$7.81M Buy
191,383
+2,709
+1% +$117K 1.44% 30
2022
Q4 		$9.7M Sell
188,674
-16,717
-8% -$801K 1.59% 26
2022
Q3 		$8.99M Buy
205,391
+6,692
+3% +$325K 1.37% 28
2022
Q2 		$10.4M Buy
198,699
+137,041
+222% +$6.98M 1.43% 22
2022
Q1 		$3.19M Sell
61,658
-877
-1% -$45.5K 0.56% 35
2021
Q4 		$3.69M Sell
62,535
-2,917
-4% -$145K 0.62% 35
2021
Q3 		$2.82M Buy
+65,452
New +$2.9M 0.51% 38

Other funds holding PFE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

ARS Wealth Advisors Group's PFE Position: Q3 2026 in Review

ARS Wealth Advisors Group increased its Pfizer (PFE) stake by 0.2% in Q3 2026, buying an estimated $1.92K and bringing the position to 36,016 shares worth $1.03M. The position accounts for 0.07% of the portfolio, ranked #95.

ARS Wealth Advisors Group first reported a position in PFE in Q3 2021 and has held it in 21 quarters since. The position peaked at $10.4M in Q2 2022. 2,000 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • ARS Wealth Advisors Group held 36,016 shares of Pfizer worth $1.03M as of Q3 2026.
  • ARS Wealth Advisors Group bought 72 Pfizer shares in Q3 2026, an estimated $1.92K.
  • Pfizer made up 0.07% of ARS Wealth Advisors Group's portfolio in Q3 2026, its #95 holding.
  • ARS Wealth Advisors Group first reported a position in Pfizer in Q3 2021 and has held it in 21 quarters since.
  • ARS Wealth Advisors Group's Pfizer position peaked at $10.4M in Q2 2022.
  • 2,000 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on ARS Wealth Advisors Group's 13F filing for Q3 2026, filed 16 Oct 2026.